Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI)
Clinical trial NCT04306471 · UNKNOWN
Trial details
- NCT number
- NCT04306471
- Sponsor
- Leonardo Clavijo
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2021-02-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.